These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 2423636

  • 1. An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization.
    Minson AC, Hodgman TC, Digard P, Hancock DC, Bell SE, Buckmaster EA.
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1001-13. PubMed ID: 2423636
    [Abstract] [Full Text] [Related]

  • 2. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
    Highlander SL, Sutherland SL, Gage PJ, Johnson DC, Levine M, Glorioso JC.
    J Virol; 1987 Nov; 61(11):3356-64. PubMed ID: 2444713
    [Abstract] [Full Text] [Related]

  • 3. Characterization and sequence analyses of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein H.
    Gompels UA, Carss AL, Saxby C, Hancock DC, Forrester A, Minson AC.
    J Virol; 1991 May; 65(5):2393-401. PubMed ID: 1707982
    [Abstract] [Full Text] [Related]

  • 4. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.
    Holland TC, Marlin SD, Levine M, Glorioso J.
    J Virol; 1983 Feb; 45(2):672-82. PubMed ID: 6187935
    [Abstract] [Full Text] [Related]

  • 5. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 6. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL, Duncan BE, Raybould TJ, Watson DH.
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [Abstract] [Full Text] [Related]

  • 7. Localization of epitopes of herpes simplex virus type 1 glycoprotein D.
    Eisenberg RJ, Long D, Ponce de Leon M, Matthews JT, Spear PG, Gibson MG, Lasky LA, Berman P, Golub E, Cohen GH.
    J Virol; 1985 Feb; 53(2):634-44. PubMed ID: 2578577
    [Abstract] [Full Text] [Related]

  • 8. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
    Kümel G, Kaerner HC, Levine M, Schröder CH, Glorioso JC.
    J Virol; 1985 Dec; 56(3):930-7. PubMed ID: 2415719
    [Abstract] [Full Text] [Related]

  • 9. Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody.
    Cohen GH, Dietzschold B, Ponce de Leon M, Long D, Golub E, Varrichio A, Pereira L, Eisenberg RJ.
    J Virol; 1984 Jan; 49(1):102-8. PubMed ID: 6197535
    [Abstract] [Full Text] [Related]

  • 10. Domains of herpes simplex virus I glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion.
    Navarro D, Paz P, Pereira L.
    Virology; 1992 Jan; 186(1):99-112. PubMed ID: 1370130
    [Abstract] [Full Text] [Related]

  • 11. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance.
    Glaser AL, de Vries AA, Dubovi EJ.
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2223-33. PubMed ID: 7561759
    [Abstract] [Full Text] [Related]

  • 12. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C, Norrby E, Mufson MA.
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.
    Cairns TM, Huang ZY, Whitbeck JC, Ponce de Leon M, Lou H, Wald A, Krummenacher C, Eisenberg RJ, Cohen GH.
    J Virol; 2014 Nov; 88(21):12612-22. PubMed ID: 25142599
    [Abstract] [Full Text] [Related]

  • 15. Virus, strain, and epitope specificities of neutralizing bovine monoclonal antibodies to bovine herpesvirus 1 glycoproteins gB, gC, and gD, with sequence and molecular model analysis.
    Levings RL, Collins JK, Patterson PA, Roth JA.
    Vet Immunol Immunopathol; 2015 Apr 15; 164(3-4):179-93. PubMed ID: 25771882
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Domain structure of herpes simplex virus 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues.
    Pereira L, Ali M, Kousoulas K, Huo B, Banks T.
    Virology; 1989 Sep 15; 172(1):11-24. PubMed ID: 2475970
    [Abstract] [Full Text] [Related]

  • 18. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies.
    Liu DX, Gompels UA, Foa-Tomasi L, Campadelli-Fiume G.
    Virology; 1993 Nov 15; 197(1):12-22. PubMed ID: 7692666
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.
    Para MF, Parish ML, Noble AG, Spear PG.
    J Virol; 1985 Aug 15; 55(2):483-8. PubMed ID: 2991571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.